Correspondence

Advice on 'third generation’ synthetic cannabinoids

Lynne Featherstone writes to the ACMD chair regarding synthetic cannabinoids.

Document

ACMD advice: ‘third generation’ synthetic cannabinoids, March 2015

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Lynne Featherstone writes to the chair of the ACMD regarding the ongoing review of the generic definitions used in the Misuse of Drugs Act 1971 and its latest advice to update drug controls on synthetic cannabinoids.

Published 11 March 2015